Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up

BACKGROUND: Botulinum toxin type-A (BTX-A) has been successfully utilized to treat trigeminal neuralgia. In this study, through the use of a new technique, the efficacy of the injection of BTX-A to the maxillary and mandibular nerves was evaluated. METHODS: A total of 27 patients were injected with...

Descripción completa

Detalles Bibliográficos
Autores principales: Türk Börü, Ülkü, Duman, Arda, Bölük, Cem, Coşkun Duman, Sanem, Taşdemir, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626289/
https://www.ncbi.nlm.nih.gov/pubmed/28953646
http://dx.doi.org/10.1097/MD.0000000000008133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626289/
https://www.ncbi.nlm.nih.gov/pubmed/28953646
http://dx.doi.org/10.1097/MD.0000000000008133

Ejemplares similares